Evidence map›Paper›PMID 25170617›Full record

ArticlePloS one2014

Upregulation of ERK1/2-eNOS via AT2 receptors decreases the contractile response to angiotensin II in resistance mesenteric arteries from obese rats.

Graziela N Hagihara, Nubia S Lobato, Fernando P Filgueira, Eliana H Akamine, Danielle S Aragão, Dulce E Casarini, Maria Helena C Carvalho, Zuleica B Fortes

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Maternal high-fat diet increases vascular contractility in adult offspring in a sex-dependent manner.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Graziela N HagiharaDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Nubia S LobatoDepartment of Biological Sciences, Division of Cardiovascular Physiology, Federal University of Goias, Jatai, Brazil.
Fernando P FilgueiraDepartment of Biological Sciences, Division of Cardiovascular Physiology, Federal University of Goias, Jatai, Brazil.
Eliana H AkamineDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Danielle S AragãoDepartment of Medicine, Division of Nephrology, Escola Paulista de Medicina, Federal University of Sao Paulo, Sao Paulo, Brazil.
Dulce E CasariniDepartment of Medicine, Division of Nephrology, Escola Paulista de Medicina, Federal University of Sao Paulo, Sao Paulo, Brazil.
Maria Helena C CarvalhoDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Zuleica B FortesDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Universidade de São Paulo · BRUniversidade Federal de Goiás · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been clearly established that mitogen-activated protein kinases (MAPKS) are important mediators of angiotensin II (Ang II) signaling via AT1 receptors in the vasculature. However, evidence for a role of these kinases in changes of Ang II-induced vasoconstriction in obesity is still lacking. Here we sought to determine whether vascular MAPKs are differentially activated by Ang II in obese animals. The role of AT2 receptors was also evaluated. Male monosodium glutamate-induced obese (obese) and non-obese Wistar rats (control) were used. The circulating concentrations of Ang I and Ang II, determined by HPLC, were increased in obese rats. Ang II-induced isometric contraction was decreased in endothelium-intact resistance mesenteric arteries from obese compared with control rats and exhibited a retarded AT1 receptor antagonist response. Blocking of AT2 receptors and inhibition of either endothelial nitric oxide synthase (eNOS) or extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) restored Ang II-induced contraction in obese rats. Western blot analysis revealed increased protein expression of AT2 receptors in arteries from obese rats. Basal and Ang II-induced ERK1/2 phosphorylation was also increased in obese rats. Blockade of either AT1 or AT2 receptors corrected the increased ERK1/2 phosphorylation in arteries from obese rats to levels observed in control preparations. Phosphorylation of eNOS was increased in obese rats. Incubation with the ERK1/2 inhibitor before Ang II stimulation did not affect eNOS phosphorylation in control rats; however, it corrected the increased phosphorylation of eNOS in obese rats. These results clearly demonstrate that enhanced AT2 receptor and ERK1/2-induced, NO-mediated vasodilation reduces Ang II-induced contraction in an endothelium-dependent manner in obese rats.

Indexed as

Angiotensin IIAngiotensin II Type 2 Receptor BlockersAnimalsBlotting, WesternEndothelium, VascularEnzyme InhibitorsImidazolesIn Vitro TechniquesMaleMesenteric ArteriesMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NG-Nitroarginine Methyl EsterNitric OxideNitric Oxide Synthase Type IIIObesityAngiotensin IIAngiotensin II Type 2 Receptor BlockersEnzyme InhibitorsImidazolesMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NG-Nitroarginine Methyl EsterNitric OxideNitric Oxide Synthase Type IIIPD 123319PyridinesReceptor, Angiotensin, Type 2SB 203580Vasoconstrictor Agents

Identifiers

PMID25170617
PMCPMC4149482
OpenAlexW2014945183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.